vs
PELOTON INTERACTIVE, INC.（PTON）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是PELOTON INTERACTIVE, INC.的1.2倍（$772.1M vs $656.5M），Revvity净利率更高（12.7% vs -5.9%，领先18.7%），Revvity同比增速更快（5.9% vs -2.6%），Revvity自由现金流更多（$161.8M vs $71.0M）
派乐腾（Peloton Interactive）是总部位于美国纽约的健身设备与媒体服务商，主打搭载联网触控屏的动感单车、跑步机、室内划船器等产品，用户付费订阅即可观看直播和录播健身课程，设备内置传感器可追踪运动功率等数据，为用户提供实时运动表现反馈，还支持排行榜功能与其他用户互动比拼。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
PTON vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.2倍
$656.5M
营收增速更快
RVTY
高出8.4%
-2.6%
净利率更高
RVTY
高出18.7%
-5.9%
自由现金流更多
RVTY
多$90.8M
$71.0M
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $656.5M | $772.1M |
| 净利润 | $-38.8M | $98.4M |
| 毛利率 | 50.5% | — |
| 营业利润率 | -2.2% | 14.5% |
| 净利率 | -5.9% | 12.7% |
| 营收同比 | -2.6% | 5.9% |
| 净利润同比 | 57.8% | 3.9% |
| 每股收益（稀释后） | $-0.09 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PTONRVTY
| Q4 25 | $656.5M | $772.1M | ||
| Q3 25 | $550.8M | $698.9M | ||
| Q2 25 | — | $720.3M | ||
| Q1 25 | — | $664.8M | ||
| Q4 24 | — | $729.4M | ||
| Q3 24 | — | $684.0M | ||
| Q2 24 | — | $691.7M | ||
| Q1 24 | — | $649.9M |
净利润PTONRVTY
| Q4 25 | $-38.8M | $98.4M | ||
| Q3 25 | $13.9M | $46.7M | ||
| Q2 25 | — | $53.9M | ||
| Q1 25 | — | $42.2M | ||
| Q4 24 | — | $94.6M | ||
| Q3 24 | — | $94.4M | ||
| Q2 24 | — | $55.4M | ||
| Q1 24 | — | $26.0M |
毛利率PTONRVTY
| Q4 25 | 50.5% | — | ||
| Q3 25 | 51.5% | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率PTONRVTY
| Q4 25 | -2.2% | 14.5% | ||
| Q3 25 | 7.5% | 11.7% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | — | 16.3% | ||
| Q3 24 | — | 14.3% | ||
| Q2 24 | — | 12.4% | ||
| Q1 24 | — | 6.8% |
净利率PTONRVTY
| Q4 25 | -5.9% | 12.7% | ||
| Q3 25 | 2.5% | 6.7% | ||
| Q2 25 | — | 7.5% | ||
| Q1 25 | — | 6.4% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | — | 4.0% |
每股收益（稀释后）PTONRVTY
| Q4 25 | $-0.09 | $0.86 | ||
| Q3 25 | $0.03 | $0.40 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | — | $0.77 | ||
| Q3 24 | — | $0.77 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | — | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $919.9M |
| 总债务越低越好 | $1.5B | — |
| 股东权益账面价值 | $-326.7M | $7.3B |
| 总资产 | $2.2B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PTONRVTY
| Q4 25 | $1.2B | $919.9M | ||
| Q3 25 | $1.1B | $931.4M | ||
| Q2 25 | — | $991.8M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $1.7B |
总债务PTONRVTY
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PTONRVTY
| Q4 25 | $-326.7M | $7.3B | ||
| Q3 25 | $-347.0M | $7.4B | ||
| Q2 25 | — | $7.6B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.7B | ||
| Q3 24 | — | $7.9B | ||
| Q2 24 | — | $7.9B | ||
| Q1 24 | — | $7.8B |
总资产PTONRVTY
| Q4 25 | $2.2B | $12.2B | ||
| Q3 25 | $2.2B | $12.1B | ||
| Q2 25 | — | $12.4B | ||
| Q1 25 | — | $12.4B | ||
| Q4 24 | — | $12.4B | ||
| Q3 24 | — | $12.8B | ||
| Q2 24 | — | $13.4B | ||
| Q1 24 | — | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $71.9M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $71.0M | $161.8M |
| 自由现金流率自由现金流/营收 | 10.8% | 21.0% |
| 资本支出强度资本支出/营收 | 0.1% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流PTONRVTY
| Q4 25 | $71.9M | $182.0M | ||
| Q3 25 | $71.9M | $138.5M | ||
| Q2 25 | — | $134.3M | ||
| Q1 25 | — | $128.2M | ||
| Q4 24 | — | $174.2M | ||
| Q3 24 | — | $147.9M | ||
| Q2 24 | — | $158.6M | ||
| Q1 24 | — | $147.6M |
自由现金流PTONRVTY
| Q4 25 | $71.0M | $161.8M | ||
| Q3 25 | $67.4M | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率PTONRVTY
| Q4 25 | 10.8% | 21.0% | ||
| Q3 25 | 12.2% | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度PTONRVTY
| Q4 25 | 0.1% | 2.6% | ||
| Q3 25 | 0.8% | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率PTONRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | 5.17× | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PTON
| Subscription And Circulation | $412.6M | 63% |
| Connected Fitness Products Segment | $243.9M | 37% |
| Product Warranty | $4.0M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
